These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 19390997

  • 1. Changes of serum and urine neutrophil gelatinase-associated lipocalin in type-2 diabetic patients with nephropathy: one year observational follow-up study.
    Yang YH, He XJ, Chen SR, Wang L, Li EM, Xu LY.
    Endocrine; 2009 Aug; 36(1):45-51. PubMed ID: 19390997
    [Abstract] [Full Text] [Related]

  • 2. Clinical value of NGAL, L-FABP and albuminuria in predicting GFR decline in type 2 diabetes mellitus patients.
    Chou KM, Lee CC, Chen CH, Sun CY.
    PLoS One; 2013 Aug; 8(1):e54863. PubMed ID: 23349979
    [Abstract] [Full Text] [Related]

  • 3. Assessment of biochemical markers in the early post-burn period for predicting acute kidney injury and mortality in patients with major burn injury: comparison of serum creatinine, serum cystatin-C, plasma and urine neutrophil gelatinase-associated lipocalin.
    Yang HT, Yim H, Cho YS, Kym D, Hur J, Kim JH, Chun W, Kim HS.
    Crit Care; 2014 Jul 14; 18(4):R151. PubMed ID: 25023056
    [Abstract] [Full Text] [Related]

  • 4. Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients.
    Bolignano D, Lacquaniti A, Coppolino G, Donato V, Fazio MR, Nicocia G, Buemi M.
    Kidney Blood Press Res; 2009 Jul 14; 32(2):91-8. PubMed ID: 19321980
    [Abstract] [Full Text] [Related]

  • 5. Serum cystatin C and serum and urine NGAL in the kidney function assessment of patients with MGUS.
    Stelmach-Goldys A, Czarkowska-Paczek B, Wyczalkowska-Tomasik A, Paczek L.
    Eur J Haematol; 2015 Feb 14; 94(2):162-8. PubMed ID: 25046079
    [Abstract] [Full Text] [Related]

  • 6. High serum and urine neutrophil gelatinase-associated lipocalin levels are independent predictors of renal progression in patients with immunoglobulin A nephropathy.
    Rhee H, Shin N, Shin MJ, Yang BY, Kim IY, Song SH, Lee DW, Lee SB, Kwak IS, Seong EY.
    Korean J Intern Med; 2015 May 14; 30(3):354-61. PubMed ID: 25995666
    [Abstract] [Full Text] [Related]

  • 7. Assessment of kidney function in diabetic patients. Is there a role for new biomarkers NGAL, cystatin C and KIM-1?
    Matys U, Bachorzewska-Gajewska H, Malyszko J, Dobrzycki S.
    Adv Med Sci; 2013 May 14; 58(2):353-61. PubMed ID: 24384771
    [Abstract] [Full Text] [Related]

  • 8. Clinical application of neutrophil gelatinase-associated lipocalin in the revised chronic kidney disease classification.
    Xiang D, Zhang H, Bai J, Ma J, Li M, Gao J, Wang C.
    Int J Clin Exp Pathol; 2014 May 14; 7(10):7172-81. PubMed ID: 25400814
    [Abstract] [Full Text] [Related]

  • 9. Comparative assessment of neutrophil gelatinase-associated lipocalin (NGAL) and cystatin C as early biomarkers for early detection of renal failure in patients with hypertension.
    Gharishvandi F, Kazerouni F, Ghanei E, Rahimipour A, Nasiri M.
    Iran Biomed J; 2015 May 14; 19(2):76-81. PubMed ID: 25864811
    [Abstract] [Full Text] [Related]

  • 10. The changes of serum sKlotho and NGAL levels and their correlation in type 2 diabetes mellitus patients with different stages of urinary albumin.
    Wu C, Wang Q, Lv C, Qin N, Lei S, Yuan Q, Wang G.
    Diabetes Res Clin Pract; 2014 Nov 14; 106(2):343-50. PubMed ID: 25263500
    [Abstract] [Full Text] [Related]

  • 11. Comparison of Neutrophil Gelatinase-Associated Lipocalin Versus B-Type Natriuretic Peptide and Cystatin C to Predict Early Acute Kidney Injury and Outcome in Patients With Acute Heart Failure.
    Palazzuoli A, Ruocco G, Pellegrini M, De Gori C, Del Castillo G, Franci B, Nuti R, Ronco C.
    Am J Cardiol; 2015 Jul 01; 116(1):104-11. PubMed ID: 25943992
    [Abstract] [Full Text] [Related]

  • 12. Detection of an earlier tubulopathy in diabetic nephropathy among children with normoalbuminuria.
    Hafez MH, El-Mougy FA, Makar SH, Abd El Shaheed S.
    Iran J Kidney Dis; 2015 Mar 01; 9(2):126-31. PubMed ID: 25851291
    [Abstract] [Full Text] [Related]

  • 13. NGAL and cystatin C: two possible early markers of diabetic nephropathy in young patients with type 1 diabetes mellitus: one year follow up.
    Papadopoulou-Marketou N, Skevaki C, Kosteria I, Peppa M, Chrousos GP, Papassotiriou I, Kanaka-Gantenbein C.
    Hormones (Athens); 2015 Mar 01; 14(2):232-40. PubMed ID: 25402375
    [Abstract] [Full Text] [Related]

  • 14. Neutrophil gelatinase-associated lipocalin (NGAL) for the early detection of contrast-induced nephropathy after percutaneous coronary intervention.
    Liebetrau C, Gaede L, Doerr O, Blumenstein J, Rixe J, Teichert O, Willmer M, Weber M, Rolf A, Möllmann H, Hamm C, Nef H.
    Scand J Clin Lab Invest; 2014 Mar 01; 74(2):81-8. PubMed ID: 24304491
    [Abstract] [Full Text] [Related]

  • 15. Renal effects of coronary artery bypass graft surgery in diabetic and non-diabetic patients: a study with urinary neutrophil gelatinase-associated lipocalin and serum cystatin C.
    Arun O, Celik G, Oc B, Unlu A, Celik JB, Oc M, Duman A.
    Kidney Blood Press Res; 2015 Mar 01; 40(2):141-52. PubMed ID: 25832128
    [Abstract] [Full Text] [Related]

  • 16. Neutrophil gelatinase-associated lipocalin and cystatin C could predict renal outcome in patients undergoing kidney allograft transplantation: a prospective study.
    Lebkowska U, Malyszko J, Lebkowska A, Koc-Zorawska E, Lebkowski W, Malyszko JS, Kowalewski R, Gacko M.
    Transplant Proc; 2009 Mar 01; 41(1):154-7. PubMed ID: 19249501
    [Abstract] [Full Text] [Related]

  • 17. Biomarkers for early detection of sickle nephropathy.
    Sundaram N, Bennett M, Wilhelm J, Kim MO, Atweh G, Devarajan P, Malik P.
    Am J Hematol; 2011 Jul 01; 86(7):559-66. PubMed ID: 21630304
    [Abstract] [Full Text] [Related]

  • 18. Neutrophil Gelatinase--Associated Lipocalin and Cystatin C Are Sensitive Markers of Renal Injury in Patients With Multiple Myeloma.
    Papassotiriou GP, Kastritis E, Gkotzamanidou M, Christoulas D, Eleutherakis-Papaiakovou E, Migkou M, Gavriatopoulou M, Roussou M, Margeli A, Papassotiriou I, Dimopoulos MA, Terpos E.
    Clin Lymphoma Myeloma Leuk; 2016 Jan 01; 16(1):29-35. PubMed ID: 26632077
    [Abstract] [Full Text] [Related]

  • 19. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in hypertensive and normotensive patients with coronary artery disease.
    Malyszko J, Bachorzewska-Gajewska H, Malyszko JS, Pawlak K, Dobrzycki S.
    Nephrology (Carlton); 2008 Apr 01; 13(2):153-6. PubMed ID: 18275504
    [Abstract] [Full Text] [Related]

  • 20. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease.
    Bolignano D, Lacquaniti A, Coppolino G, Donato V, Campo S, Fazio MR, Nicocia G, Buemi M.
    Clin J Am Soc Nephrol; 2009 Feb 01; 4(2):337-44. PubMed ID: 19176795
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.